WT
ALNY icon

Whittier Trust’s Alnylam Pharmaceuticals ALNY Stock Holding History

Whittier Trust’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29.4K Buy
94
+4
+4% +$1.21K ﹤0.01% 960
2026
Q1 		$29.7K Buy
90
+21
+30% +$7.15K ﹤0.01% 925
2025
Q4 		$28K Hold
69
– – ﹤0.01% 966
2025
Q3 		$31.5K Hold
69
– – ﹤0.01% 938
2025
Q2 		$22.5K Buy
69
+33
+92% +$9.13K ﹤0.01% 1084
2025
Q1 		$9.72K Hold
36
– – ﹤0.01% 1217
2024
Q4 		$8.47K Hold
36
– – ﹤0.01% 1277
2024
Q3 		$9.9K Hold
36
– – ﹤0.01% 1264
2024
Q2 		$8.75K Hold
36
– – ﹤0.01% 1265
2024
Q1 		$5.38K Sell
36
-1
-3% -$167 ﹤0.01% 1347
2023
Q4 		$7.08K Sell
37
-1
-3% -$170 ﹤0.01% 1274
2023
Q3 		$6.73K Buy
38
+2
+6% +$382 ﹤0.01% 1325
2023
Q2 		$6.84K Hold
36
– – ﹤0.01% 1322
2023
Q1 		$7.21K Sell
36
-6
-14% -$1.26K ﹤0.01% 1350
2022
Q4 		$9.98K Buy
42
+6
+17% +$1.28K ﹤0.01% 1289
2022
Q3 		$7K Hold
36
– – ﹤0.01% 1387
2022
Q2 		$5K Hold
36
– – ﹤0.01% 1427
2022
Q1 		$6K Hold
36
– – ﹤0.01% 1414
2021
Q4 		$6K Hold
36
– – ﹤0.01% 1379
2021
Q3 		$7K Hold
36
– – ﹤0.01% 1287
2021
Q2 		$6K Hold
36
– – ﹤0.01% 1332
2021
Q1 		$5K Hold
36
– – ﹤0.01% 1344
2020
Q4 		$5K Hold
36
– – ﹤0.01% 1232
2020
Q3 		$5K Hold
36
– – ﹤0.01% 1216
2020
Q2 		$5K Hold
36
– – ﹤0.01% 1157
2020
Q1 		$4K Sell
36
-28
-44% -$3.23K ﹤0.01% 1234
2019
Q4 		$7K Buy
64
+28
+78% +$2.79K ﹤0.01% 1181
2019
Q3 		$3K Buy
+36
New +$2.85K ﹤0.01% 1314

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Whittier Trust's ALNY Position: Q2 2026 in Review

Whittier Trust increased its Alnylam Pharmaceuticals (ALNY) stake by 4.4% in Q2 2026, buying an estimated $1.21K and bringing the position to 94 shares worth $29.4K. The position accounts for ﹤0.01% of the portfolio, ranked #960.

Whittier Trust first reported a position in ALNY in Q3 2019 and has held it in 28 quarters since. The position peaked at $31.5K in Q3 2025. 790 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Whittier Trust held 94 shares of Alnylam Pharmaceuticals worth $29.4K as of Q2 2026.
  • Whittier Trust bought 4 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $1.21K.
  • Alnylam Pharmaceuticals made up ﹤0.01% of Whittier Trust's portfolio in Q2 2026, its #960 holding.
  • Whittier Trust first reported a position in Alnylam Pharmaceuticals in Q3 2019 and has held it in 28 quarters since.
  • Whittier Trust's Alnylam Pharmaceuticals position peaked at $31.5K in Q3 2025.
  • 790 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Whittier Trust's 13F filing for Q2 2026, filed 28 Jul 2026.